Search results for "Skin Neoplasm"

showing 10 items of 283 documents

Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage

2017

Abstract The identification of reciprocal interactions between tumor-infiltrating immune cells and the microenviroment may help us understand mechanisms of tumor growth inhibition or progression. We have assessed the frequencies of tumor-infiltrating and circulating γδ T cells and regulatory T cells (Treg) from 47 patients with squamous cell carcinoma (SCC), to determine if they correlated with progression or survival. Vδ1 T cells infiltrated SSC tissue to a greater extent than normal skin, but SCC patients and healthy subjects had similar amounts circulating. However, Vδ2 T cells were present at higher frequencies in circulation than in the tissue of either cancer patients or healthy donor…

Male0301 basic medicineCancer ResearchChemokineCell typeSkin Neoplasmsmedicine.medical_treatmentImmunologyCell03 medical and health sciencesInterleukin 21Lymphocytes Tumor-Infiltrating0302 clinical medicineImmune systemT-Lymphocyte SubsetsTumor MicroenvironmentmedicineHumansCytotoxic T cellImmunology; Cancer ResearchAgedNeoplasm StagingAged 80 and overTumor microenvironmentbiologyImmunotherapyMiddle Aged030104 developmental biologymedicine.anatomical_structureImmunologyCarcinoma Squamous Cellbiology.proteinCytokinesFemale030215 immunologyCancer Immunology Research
researchProduct

Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort…

2021

BackgroundCheckpoint inhibitors revolutionized the treatment of metastatic melanoma patients. Although tumor burden and lactate dehydrogenase (LDH) are associated with overall survival (OS), the impact of tumor growth kinetics remains elusive and in part contradictory. The aims of this study were to develop a novel simple and rapid method that estimates pretreatment metastatic growth rate (MGR) and to investigate its prognostic impact in melanoma patients treated with antiprogrammed death receptor-1 (PD-1) antibodies.MethodsMGR was assessed in three independent cohorts of a total of 337 unselected consecutive metastasized stage IIIB–IV melanoma patients (discovery cohort: n=53, confirmation…

Male0301 basic medicineOncologyCancer ResearchSkin NeoplasmsTime Factors2437Programmed Cell Death 1 ReceptorPembrolizumabMetastasis0302 clinical medicineRisk FactorsImmunotherapy BiomarkersImmunology and Allergy1506Immune Checkpoint InhibitorsRC254-282MelanomaNeoplasms. Tumors. Oncology. Including cancer and carcinogensMiddle Agedddc:EuropeNivolumabTreatment OutcomeOncology030220 oncology & carcinogenesisCohortMolecular MedicineFemaleimmunotherapyNivolumabCohort studytumormedicine.medical_specialtyImmunologyAntibodies Monoclonal HumanizedRisk Assessment03 medical and health sciencesPredictive Value of TestsInternal medicinemelanomamedicineHumansCell ProliferationNeoplasm StagingRetrospective StudiesPharmacologyProportional hazards modelbusiness.industrybiomarkersReproducibility of Resultsmedicine.disease030104 developmental biologyTomography X-Ray ComputedbusinessBrain metastasis
researchProduct

Overall survival in patients with BRAF-mutant melanoma receiving encorafenib plus binimetinib versus vemurafenib or encorafenib (COLUMBUS): a multice…

2018

Summary Background Encorafenib plus binimetinib and encorafenib alone improved progression-free survival compared with vemurafenib in patients with BRAF V600 -mutant melanoma in the COLUMBUS trial. Here, we report the results of the secondary endpoint of overall survival. Methods COLUMBUS was a two-part, randomised, open-label, phase 3 study done at 162 hospitals in 28 countries. Eligible patients were aged at least 18 years with histologically confirmed, locally advanced, unresectable, or metastatic cutaneous melanoma, or unknown primary melanoma, BRAF V600E or BRAF V600K mutation, an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, and were treatment naive or had pr…

Male0301 basic medicineOncologySkin NeoplasmsTime FactorsMedizinPhases of clinical researchGene mutationchemistry.chemical_compound0302 clinical medicineAntineoplastic Combined Chemotherapy ProtocolsVemurafenibMelanomaAged 80 and overTrametinibSulfonamides10177 Dermatology ClinicBinimetinibMiddle AgedProgression-Free SurvivalPhenotypeOncologyTolerability030220 oncology & carcinogenesisDisease ProgressionFemale2730 Oncologymedicine.drugAdultProto-Oncogene Proteins B-rafmedicine.medical_specialty610 Medicine & healthYoung Adult03 medical and health sciencesInternal medicineBiomarkers TumormedicineHumansGenetic Predisposition to DiseaseProgression-free survivalProtein Kinase InhibitorsAgedPerformance statusbusiness.industry030104 developmental biologyVemurafenibchemistryMutationBenzimidazolesCarbamatesbusinessThe Lancet Oncology
researchProduct

Downregulation of intratumoral expression of miR-205, miR-200c and miR-125b in primary human cutaneous melanomas predicts shorter survival

2018

AbstractWhile only 15–25 percent of melanoma patients develop distant metastasis and die, this disease is still responsible for the majority of skin cancer-related deaths. The availability of adjuvant therapies makes the selection of high-risk patients essential. We evaluated the intratumoral expression of ten miRNAs in primary melanomas in relation to its ability to predict melanoma survival. To this end, we correlated miRNA expression in 132 cryopreserved primary and metastatic tumors with clinicopathological factors and clinical outcome. We found sequential downregulation of intratumoral expression of miR-125b, miR-182, miR-200c and miR-205 over the full spectrum of melanoma progression.…

Male0301 basic medicineSkin Neoplasmsmedicine.medical_treatmentlcsh:MedicineDown-RegulationDiseaseArticleMetastasisExtracellular matrix03 medical and health sciences0302 clinical medicineDownregulation and upregulationCell MovementmicroRNABiomarkers TumorTumor Cells CulturedmedicineHumansNeoplasm Invasivenesslcsh:ScienceMelanomaAgedCell ProliferationMultidisciplinarybusiness.industryMelanomalcsh:RPrognosismedicine.diseaseIn vitroGene Expression Regulation NeoplasticSurvival RateMicroRNAs030104 developmental biology030220 oncology & carcinogenesisDisease ProgressionCancer researchlcsh:QFemalebusinessAdjuvantFollow-Up StudiesScientific Reports
researchProduct

Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients

2018

Male0301 basic medicinemedicine.medical_specialtySkin NeoplasmsDermatologyGastroenterologyBody Mass IndexSerologyCorrelation03 medical and health sciences0302 clinical medicineText miningInternal medicineVitamin D and neurologyHumansMedicineVitamin DMelanomaPathologicalmelanoma; vitamin D; Body Mass Indexbusiness.industryMelanomaMiddle AgedPrognosismedicine.disease030104 developmental biology030220 oncology & carcinogenesisFemalebusinessBody mass indexGiornale Italiano di Dermatologia e Venereologia
researchProduct

Complete tumor prevention by engineered tumor cell vaccines employing nonviral vectors.

2004

We report that 100% mice survival after tumor challenge is achieved with cytokine-engineered cells employing nonviral lipoplexes and without using viral vectors. We describe this effect with cytokine-secreting tumor cell vaccines, based on cell clones or fresh transfected cells. Tumor cells were transfected with murine granulocyte-macrophage colony-stimulating factor (GM-CSF) or IL-4 plasmids employing the cationic lipid DOTAP, were irradiated (150 Gy) and kept frozen until use. The transfection efficacy was analyzed by qRT-PCR and flow cytometry. Vaccination induced potent antitumor rejection, resulting in 100% mice survival. Furthermore, the antitumor immunity was long lasting, since a tw…

MaleCancer ResearchSkin NeoplasmsGenetic enhancementCellGenetic VectorsAntineoplastic AgentsBiologyCancer VaccinesViral vectorFlow cytometryMicemedicineAnimalsMolecular BiologyMelanomaInterleukin 4medicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionMelanomaGranulocyte-Macrophage Colony-Stimulating FactorTransfectionGenetic TherapyNeoplasms Experimentalmedicine.diseaseFlow CytometryVirologySurvival AnalysisMice Inbred C57BLmedicine.anatomical_structureGranulocyte macrophage colony-stimulating factorMolecular MedicineFemaleInterleukin-4Genetic Engineeringmedicine.drugCancer gene therapy
researchProduct

Localized hypothermia: impact on oxygenation, microregional perfusion, metabolic and bioenergetic status of subcutaneous rat tumours.

1998

The effect of localized hypothermia on microcirculatory and metabolic parameters in s.c. DS sarcomas on the hind foot dorsum of Sprague-Dawley rats was investigated. Tumours were cooled by superfusion of the tumour surface with cooled saline solution to 25 degrees C or 15 degrees C. Control tumours remained at 35 degrees C. These temperatures were maintained for 30 min. In tumour oxygenation measurements, hypothermia at 25 degrees C and 15 degrees C caused progressive decreases in the size of the fraction of pO2 measurements between 0 and 2.5 mmHg together with a reduction in pO2 variability. No significant changes in median or mean pO2 or in the fraction of pO2 measurements between 0 and 5…

MaleCancer Researchmedicine.medical_specialtyPathologySkin Neoplasmsmedicine.medical_treatmentBlood viscosityMicrocirculationRats Sprague-DawleyOxygen ConsumptionHypothermia InducedInternal medicinemedicineLaser-Doppler FlowmetryAnimalsSalinebusiness.industryMicrocirculationOxygenationLaser Doppler velocimetryHypothermiaBlood ViscosityRatsRed blood cellEndocrinologymedicine.anatomical_structureOncologySarcoma Experimentalmedicine.symptombusinessPerfusionResearch ArticleBritish Journal of Cancer
researchProduct

Comparative tumorigenicity of picene and dibenz[a,h]anthracene in the mouse

1990

The carcinogenic activity of the two polycyclic aromatic hydrocarbons (PAHs), picene (benzo[a]chrysene) and dibenz[a,h]anthracene (DBA), was determined in NMRI mice by five different experimental protocols in order to find out if picene is a carcinogen as predicted by recent quantum mechanical calculations in contrast to earlier observations which could not confirm any carcinogenic activity of picene. Single s.c. treatment of adult mice with picene or DBA (308 nmol/animal, each) led to the formation of fibrosarcomas in 63.3% of treated animals regardless of the PAH used. Chronic epicutaneous application of both PAHs (total dose 1.36 mumol) to the back of mice resulted in the development of …

MaleChryseneCancer ResearchLung NeoplasmsSkin NeoplasmsTime FactorsRatónMice Inbred Strainsmedicine.disease_causeChrysenesMicechemistry.chemical_compoundReference ValuesBiological propertyBenz(a)AnthracenesmedicineAnimalsDibenz(ah)anthraceneCarcinogenAnthraceneGeneral MedicineMolecular biologychemistryPiceneCarcinogensFemaleCarcinogenesisCarcinogenesis
researchProduct

Infantile hemangiomas with minimal or arrested growth: A retrospective case series

2018

Background/objectives Infantile hemangiomas (IH) with minimal or arrested growth (MAG) constitute a distinctive subset of IH based on their clinical characteristics and natural history. They are often confused with capillary malformations. Methods A retrospective observational study has been carried out in which clinical and perinatal characteristics have been evaluated in all IH-MAG evaluated in our Dermatology Department in a 5-year period (January 2013-December 2017). Results A total of 14 IH-MAG affecting 13 patients were identified (10 girls and 3 boys). All were born full term, with a mean birth weight of 3448 g for girls vs 3540 g for boys, corresponding to the 72nd percentile for bo…

MaleInvolution (mathematics)Pediatricsmedicine.medical_specialtySkin NeoplasmsBirth weightAdrenergic beta-AntagonistsDermatologyPropranololHemangioma030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinemedicineHumansChildRetrospective StudiesHigh birth weightFull Termbusiness.industryInfantRetrospective cohort studymedicine.diseasePropranololNatural historyChild Preschool030220 oncology & carcinogenesisPediatrics Perinatology and Child HealthDisease ProgressionFemaleHemangiomabusinessmedicine.drugPediatric Dermatology
researchProduct

Screening for distress in routine oncological care-a survey in 520 melanoma patients.

2012

Introduction Despite the increasing incidence of melanoma little is known about patients' emotional distress associated with this disease. Supplemented by the problem list (PL), the distress thermometer (DT) is a recommended screening instrument to measure psychosocial distress in cancer patients. Our objective was to explore the acceptance and the feasibility of the DT and PL as a concise screening tool in an ambulatory setting for routine care and to elucidate determinants of distress in melanoma patients with regard to sociodemographic and clinical variables. Methods Consecutive melanoma outpatients were asked to complete the DT with the PL prior to their scheduled consultation. Demograp…

MaleMelanomasPediatricsSkin NeoplasmsNon-Clinical MedicineEpidemiologyEmotionsProblem listlcsh:MedicineDiseaseSocial and Behavioral SciencesQuality of lifeRisk FactorsSurveys and QuestionnairesOutpatientsMass ScreeningPsychologyYoung adultlcsh:ScienceMelanomaSkin TumorsAged 80 and overMultidisciplinaryIncidence (epidemiology)Malignant MelanomaMiddle AgedDistressClinical PsychologyMental HealthOncologyMedicineFemalePsychosocialResearch ArticleTest EvaluationAdultmedicine.medical_specialtyAdolescentSocial PsychologyPsychological StressMalignant Skin NeoplasmsDermatologyYoung AdultDiagnostic MedicinemedicineHumansPsychiatryMass screeningAgedBehaviorHealth Care Policybusiness.industrylcsh:RCancers and NeoplasmsSurvey MethodsHealth Care SurveysQuality of Lifelcsh:QbusinessStress PsychologicalPLoS ONE
researchProduct